Kazia Therapeutics
KZIA
8 hedge funds and large institutions have $671K invested in Kazia Therapeutics in 2019 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 1 closing their positions.
18% more capital invested
Capital invested by funds: $568K → $671K (+$103K)
0% more funds holding
Funds holding: 8 → 8 (0)
0% less ownership
Funds ownership: 0.01% → 0.01% (-0%)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$24.4K |
| 2 |
Renaissance Technologies
New York
|
+$5.71K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$5.52K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$1.14K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$49K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Morgan Stanley
New York
| $319K | +$24.4K | +128 | +10% |
|
|
2
Renaissance Technologies
New York
| $156K | +$5.71K | +30 | +4% |
|
|
HAG
3
HighPoint Advisor Group
Downers Grove,
Illinois
| $142K | – | – | – |
|
|
TW
4
Transform Wealth
Greenwood Village,
Colorado
| $45K | – | – | – |
|
|
5
UBS Group
Zurich,
Switzerland
| $6K | +$5.52K | +29 | +1,450% |
|
|
SPIA
6
Steward Partners Investment Advisory
New York
| $2K | – | – | – |
|
|
7
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $1K | +$1.14K | +6 | New |
|
|
RE
8
RBC Europe
London,
United Kingdom
| $139 | – | – | – |
|
|
9
Citadel Advisors
Miami,
Florida
| – | -$49K | -256 | Closed |
|
KZIA Hedge Fund Activity: Q4 2019 in Review
8 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Kazia Therapeutics (KZIA) for Q4 2019, worth a combined $671K — up 18% from $568K a quarter earlier.
Fund positioning in KZIA was balanced in Q4 2019: 1 fund opened new positions, 1 closed out, 3 added to existing stakes and 0 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $24.4K. The largest seller was Citadel Advisors, exiting entirely with an estimated $49K sold.
- 8 institutional investors held Kazia Therapeutics (KZIA) as of Q4 2019, unchanged from Q3 2019.
- Funds reported $671K of Kazia Therapeutics stock for Q4 2019, up 18% quarter-over-quarter.
- 1 fund opened new Kazia Therapeutics positions in Q4 2019 and 1 closed out, a net change of 0 holders.
- The largest Kazia Therapeutics buyer in Q4 2019 was Morgan Stanley, an estimated $24.4K added.
- The largest Kazia Therapeutics seller in Q4 2019 was Citadel Advisors, an estimated $49K sold.
Based on aggregated 13F filings for Q4 2019.